Showing posts with label Market Forecast. Show all posts
Showing posts with label Market Forecast. Show all posts

Wednesday, 18 January 2017

Steam Autoclave Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016 - 2024

The global steam autoclaves market is marked by intense competitive rivalry and high entry barriers for new vendors, typical of markets featuring high consolidation, reports a recent study by Transparency Market Research (TMR). The oligopolistic market witnesses the dominance of companies such as STERIS, Getinge Group, and Johnson & Johnson, which collectively held close to two-third of the overall market in 2015.
The presence of a very small number of product manufacturers, preference of buyers for long-term contracts with steam autoclave devices manufacturers, and broad product portfolios have further reinforced the standing of leading vendors in the market. Product innovations, production of economic products, and strategies aimed at expansion in emerging regional markets could aid small vendors in the market carve out new growth channels in the near future. Other notable vendors operating amid intense competition in the global steam autoclave market are 3M Health Care, Belimed Group, CISA Group, Matachana Group, CISA Group, and SAKURA SI CO., LTD.
Rising Number of Surgeries and Hospital-acquired Infections Stimulate Adoption of Steam Autoclaves in Healthcare Settings
The vast increase in the number of surgical procedures undertaken across the globe every year has played a major role in the increased consumption of steam autoclaves globally in the past few years. The Centers for Disease Control and Prevention states that in U.S. alone, nearly 46.5 mn surgeries and around 5 mn endoscopies are performed every year. In other regions as well, such as the developing parts of Asia Pacific, which are marked by large population bases and flourishing medical tourism industries, a massive rise in the number of surgical procedures has been seen in the past few years.
Compounding the need for effective sterilization mechanisms in healthcare settings in addition to abovementioned factor is the concern regarding rising prevalence of nosocomial infections across the globe. These factors, in addition to the rising focus on patient safety, will allow the global steam autoclave market gain traction in the next few years.
Technological Advancements to Fuel Market’s Growth
The market has witnessed the introduction of several technologically advanced and increasingly effective products such as E-beam and gamma irradiation, which are further boosting the market’s growth prospects. High product compatibility and low cost of these new products are expected to help the global steam autoclave market gain significant momentum over the forecasting horizon.
However, the increased usage of disposable devices across healthcare settings, which are not meant to be reused and require little or no sanitization over their usable life, could emerge as a major restraint for the overall growth of the market. Moreover, the imposition of excise duty taxes on the manufacturers of medical devices is also expected to hamper the overall profitability of steam autoclaves for vendors, thus resulting in increased product prices. This factor could also have a negative impact on the market’s growth prospects, especially in cost-sensitive developing regions.
In terms of popularity of product varieties available in the market, including traditional steam autoclaves and tabletop steam autoclaves, the market is again highly consolidated. The segment of traditional autoclaves accounted for a share of over 91% in the market in 2015. The segment is also expected to expand at the highest CAGR of 5.8% over the period between 2016 and 2024. North America was the leading regional market in 2015, with nearly 40% share in the market in terms of revenue in 2015.
On a whole, the global autoclave market was worth US$1.57 bn in 2015. Expected to rise at a healthy 5.7% CAGR from 2016 to 2024, the market is projected to touch US$2.57 bn by 2024.
This review is based on a latest market intelligence report published by Transparency Market Research, titled “Steam Autoclave Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Thursday, 12 January 2017

Nebulizers Market: Large Participant Pool Makes for Fragmented Competitive Landscape

A nebulizer is an electrically powered or battery operated instrument that converts liquid medication into mist. Nebulizer is one of the preferred choices for the treatment of asthma, cystic fibrosis (CFTR) and COPD (chronic obstructive pulmonary disease). This facilitates penetration of the medicine into the lungs of patients when inhaled through the mouth or a face mask. The nebulizers market in India is dominated by various devices powered by electric current and rechargeable batteries. Increasing prevalence of various respiratory disorders such as asthma, COPD, and CFTR coupled with rising geriatric population and deteriorating air quality in major cities of India fuel the growth of the nebulizers market in India.
This research report explains various advancements occurring in this market and analyzes the nebulizers market in India by products and geography. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments that are provided in the report. Moreover, executive summary comprises waterfall chart representing the nebulizers market in India by type in terms of INR Mn in 2014 which is drawn on the basis of most attarctive segment of the market. Comparative analysis has also been included in the executive summary that demonstrates the percentage market share of each segments in 2014 and 2023 respectively.
This report provides in-depth analysis of the nebulizers market in India. The stakeholders for this report include companies involved in the manufacture of nebulizers, kits and accessories and supply to to the hospitals and homes. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different zones of India. The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the nebulizers market in the current and future scenario. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the nebulizers market in India. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in India.
Based on the product, the nebulizers market in India has been segmented as pneumatic nebulizer, ultrasonic nebulizers, mesh nebulizer and nebulizer kits. Pneumatic nebulizer comprises pressurized gas supply that assists in pushing medication toward the mouth. Compressed gas is delivered through a jet (valve) that creates negative pressure on the medication tank to release the medication. An ultrasonic nebulizer uses electric current to produce high frequency vibrations in a container of fluid (medications) to break up the fluid into aerosol particles. Mesh nebulizers create vibrations (piezo) that enable the flow of liquid formulation (medicine) through a fine mesh (aperture plate) to develop aerosol medication.
Region wise, the nebulizer market in India has been differentiated into five major regions: North Zone, South Zone, East Zone, West Zone, and Central/ Zone. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the India nebulizers market in various regions has been provided in this section. The report provides market estimation of nebulizers market in India in terms of revenue (INR Mn) for all the segments and sub segments with CAGR % for period 2015 to 2023, considering 2014 as the base year. The report also provides the volume of nebulizers for all the segments and sub segments with CAGR % for period 2015 to 2023. Furthermore, the report incorporates market attractiveness analysis by product category that depicts the most attractive product segment in India during the forecast period from 2015 to 2023.
This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the nebulizers market in India. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Omron Healthcare, Philips Healthcare, CareFusion Corporation (BD), Nuilfe, Bhasins and Sons, Respirotec are among others.

Friday, 6 January 2017

Steam Autoclave Market: Business Challenges, Emerging Technologies & Competitive Landscape

The vast rise in the number of surgical procedures undertaken globally, the huge surge in a variety of infections affecting humans, and the alarming rise in the occurrence of hospital-acquired infections has increased the focus on the critical need of effective sanitization practices and devices in healthcare environments. Steam autoclaves, which play a key role in the sterilization of surgical devices and healthcare waste in healthcare environments, are thus witnessing a significant rise in global demand.
In the intensely competitive and consolidated global market for steam autoclaves, emerging economies such as Latin America and Asia Pacific are emerging as the future growth destinations for companies struggling to gain sustainable returns. The market has demonstrated high growth opportunities for advanced product varieties based on novel technologies such as gamma irradiation and E-beam (electron beam) irradiation.
According to a recent market research report by Transparency Market Research, the opportunity in the global steam autoclave market was pegged at US$1.57 bn in 2015. Rising at a promising CAGR of 5.7% over the period between 2016 and 2024, the market is expected to reach US$2.57 bn by 2024.
Q. What role are developed economies playing in the development of the global steam autoclave market?
A. Developed economies across North America and Europe presently hold commanding positions in the market for steam autoclaves and play a key role in its overall development in terms of new product launches and technological advancements. North America alone accounted for a massive 40% of the global steam autoclave market in 2015, chief reason being the vast number of surgeries taking place in the region every year. Reports suggest that in the U.S. alone, nearly 45 mn surgeries take place annually on an average.
This significantly raises the concern and potential of prevalence of hospital-acquired infections, calling the intense need for effective sanitation practices across healthcare infrastructures in North America and Europe. Apart from this, the strict observance of many stringent rules with the aim of enhancing patient safety in healthcare premises is expected to influence the adoption of steam autoclaves in these regions at an encouraging pace in the next few years.
Q. Are developed economies also expected to remain at the forefront of market’s future development?
A. Despite the dominance of North America and Europe, the steam autoclave market is expected to gain the most lucrative returns from emerging economies in regions such as Asia Pacific and Latin America in the next few years. The market for steam autoclave in Asia Pacific, especially, is expected to lead to vast growth opportunities for the global steam autoclave market owing to the increased focus on development of healthcare infrastructure across countries such as India, China, and South Korea. The market in Asia Pacific is also expected to outpace the markets across North America and Europe in terms of growth rate over the period between 2016 and 2024, exhibiting a nearly 8% CAGR.
Owing to this factor, many leading companies in the global steam autoclave market are venturing into the Asia Pacific market through mergers, acquisitions, and consolidation strategies with vendors native to the region or through establishment of operations and manufacturing facilities. Introduction of economic products could help vendors tap the vast untapped opportunities in the region with ease.

Thursday, 5 January 2017

Alarming Prevalence of Cardiovascular Diseases to Boost Global Cardiac Rehabilitation Market

Cardiovascular diseases have surfaced as a major concern in the medical and healthcare industry. As elderly people are more prone to these diseases, the significant increase in the global geriatric population has augmented the risk of their prevalence, which consequently, is having a phenomenal impact on the demand for cardiac rehabilitation measures across the world.
According to Transparency Market Research (TMR), the global market for cardiac rehabilitation offered an opportunity of US$1.0 bn in 2015. Boosted by the rising incidence of cardiac arrest, heart failure, and other cardiovascular diseases, the opportunity of this market is likely to expand at a CAGR of 5.40% during the period from 2016 to 2024 and reach a value of US$1.6 bn by the end of 2024.
Through this blog post, analysts at TMR are answering some of the most important questions about the global cardiac rehabilitation market:
What are the key driving forces behind the growth of the global cardiac rehabilitation market?
The surge in the prevalence of cardiovascular diseases across the world is the key factor behind the tremendous growth of the global market for cardiac rehabilitation. Apart from this, the technological advancements in the medical and healthcare infrastructure, rise in the purchasing power of consumers, and the awareness about the role of cardiac rehabilitation in the treatment of various cardiovascular diseases are also boosting this market considerably.
Which of the geographical segments is likely to dominate the global market for cardiac rehabilitation?
North America, which has been leading the global market for cardiac rehabilitation over the last few years due to the high disposable income of people, enabling them to spend on expensive treatment services, is likely to continue its leading streaks in the forthcoming years with a majority share.
Other regional markets, specifically Europe and Asia Pacific are also projected to witness strong growth over the next few years, thanks to the growing awareness about cardiac rehabilitation and its advantages. The advancing technology and the state-of-art medical and healthcare infrastructure are expected to support the Europe market for cardiac rehabilitation while the Asia Pacific market is likely to gain from the improving economic conditions in developing nations. Between 2016 and 2024, the market for cardiac rehabilitation is estimated to expand at a CAGR of 6.80%, higher than all other regional markets.
What are the main strategies market players are adopting for the development of their businesses?
Mostly, the key players are relying on product innovation for business development. Price competition is another significant strategy, participants are adopting to gain an edge over their competitors. Going forward, the leading companies are expected to shift their focus towards strategic alliances, mergers, and acquisitions to enhance their visibility in the global market.

Friday, 30 December 2016

Medical Lifting Slings Market - An Emerging Worldwide Industry

According to a new market research report published by Transparency Market Research “Medical Lifting Slings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”, the global medical lifting slings market was valued at US$391.8 mn in 2015 and is estimated to reach US$910.6 mn in 2024, expanding at a CAGR of 9.2% from 2016 to 2024.
Medical lifting slings are devices used in hospitals and nursing homes to transfer patients who have restricted mobility. The medical lifting slings market is driven by factors such as rising geriatric population, favorable government initiatives, and increasing incidence of lifestyle diseases. Moreover, increasing number of accidents and partial immobility incidences have fueled demand and growth of the market in the last decade. However, lack of technical expertise and proper training to handle patients with medical lifting slings in emerging economies coupled with difficulties in handling obese patients with lifting slings hampers market growth. The global medical lifting slings market was valued at US$391.8 mn in 2015 and is projected to reach US$910.6 mn by 2024, expanding at a CAGR of 9.2% from 2016 to 2024.
The universal sling segment dominated the medical lifting slings market in 2015. The dominance of this segment was majorly due to rising demand for universal lifting slings globally and comfortable and secure seating structure. The bariatric sling segment held the smallest share of the market in 2015 due to low average cost compared to other medical lifting sling products.
The universal sling segment is expected to gain market share in 2024 due to comfortable and secure seating structure. The transfer and toileting sling segment is likely to expand at a high CAGR during the forecast period. High growth rate of this segment is attributed to introduction of new supporting applications to provide better quality of life for patients and higher penetration in developing regions.
In terms of sling point, the 4 point sling segment held the largest share of the medical lifting slings market in 2015. The segment is expected to gain market share in 2024, as most products, such as bathing, spa, and hammock slings, fall under this segment. The u-shape sling segment is also estimated to witness strong growth during the forecast period as shorter lifespan results in purchase in large quantity by dealers.
The hospitals end-user segment accounted for the largest share of the market in 2015. The segment is expected to dominate the market during the forecast period. The dominance of the segment is primarily due to high adoption rate and government initiatives to train hospital nurses. Assisted living facilities and home health care have witnessed significant acceptance. Hence, the segment is likely to expand at the highest growth rate in the next few years
The global medical lifting slings market is fragmented, with the presence of many players in the market. Major players operating in the global medical lifting slings market are ArjoHuntleigh, Argo Medical, Inc., Bestcare, LLC, Drive DeVilbiss Healthcare, Etac AB, DJO Global, GF Health Products, Inc., Joerns Healthcare, LLC, Invacare Corporation, and Prism Medical, among others.

Hearing Aids Market: High Prevalence of Hearing Impairment among Adults Fuels Demand

Early detection and treatment of hearing loss can mitigate the severity of deafness and could improve the condition of those suffering from the condition. As per World Health Organization, in 2015 the hearing aid production globally, hardly met 10% of the total need and a meager 3% of demand across developing countries. This provides the global hearing aids market with substantial opportunities to gain from in the forthcoming years.
As per Transparency Market Research (TMR), the global hearing aids market is expected to reach US$7.01 bn by 2024, from US$4.7 bn in 2015. Between 2016 and 2024, the global hearing aids market is thus expected to surge at a CAGR of 4.5%.
Increasing Geriatric Population and Awareness to Boost Sales of Hearing Aids
As aged people are more prone to develop hearing impairment, the sales of hearing aids are directly impacted by the current geriatric demographic dynamics in worldwide. In the last of few years, the awareness level among patients and their families regarding hearing impairment has considerably increased. This, combined with the recent advances in the hearing aid technology, is boosting sales of hearing aids worldwide. Furthermore, the advent of rechargeable hearing aids with long lasting and quick charging features will also augment the market’s growth.
Opportunities for the Market in Europe to be Most Lucrative
Regionally, Europe has been exhibiting the most attractive opportunities for companies in the hearing aids market. It emerged dominant with a share of 39% in the global market in 2015. The presence of a large pool of aged people across Western Europe and the increasing willingness among consumers to spend on advanced medical devices have helped Europe attain the lead in the global hearing aids market. The fact that several of the prominent names in the industry are domiciled in the region has also augured well for the market. TMR has pegged the value of the Europe hearing aids market at US$1.8 bn in 2015 and forecasts it to reach US$2.6 bn by the end of 2024, rising at a CAGR 4.1% from 2015 to 2024.
However, the market in Asia Pacific is expected to grow at a fast pace during the forecast period. The prevalence of considerably high unmet medical needs and the rising investment in the health care infrastructure create immense opportunities for sale of hearing aids in Asia Pacific. Besides this, governments across emerging economies are making considerable efforts to educate people about conditions such as health impairments have fuelled demand for hearing aids in the region. As per TMR, the regional market is expected to rise at a CAGR of 5.2% between 2016 and 2024.
Increasing Incidence of Hearing Loss in Children to Necessitate Development of New Products
By end user, the global hearing aids market is bifurcated into adult and pediatric. Of these, the adult segment held approximately 94.83% of the market in 2015.The incidence of hearing impairment is higher in developing and under-developed countries because of the high geriatric population in these countries. However, in the forecast period growth exhibited by the pediatric segment is expected to be faster due to the rising prevalence of hearing loss among children.
Key players in this market are Sonova AG (Switzerland), William Demant Holding (Denmark), Siemens Healthcare (Germany), GN ReSound A/S (Denmark), Starkey (U.S.), and Widex A/S (Denmark), among others.

Tuesday, 20 December 2016

Increasing Number of Participants in India Nebulizers Market will Compete Feverishly on Price, says TMR

Thanks to growing pollution levels, the incidence of respiratory disorders is on the rise in India. This has fueled the demand for nebulizers remarkably in the country. In 2014, the India nebulizers market stood at INR575.6 mn. The dramatic growth in the cases of asthma, cystic fibrosis, and chronic obstructive pulmonary diseases is anticipated to boost the adoption of nebulizers among Indian citizens in the coming years. According to experts, the demand for these instruments will rise at a CAGR of 25.80% between 2015 and 2023 and reach an opportunity of INR4,703.4 mn by the end of 2023.
Aptness for all Types of Medications Drive Demand for Pneumatic Nebulizers
In India, the nebulizers market comprises pneumatic nebulizer, mesh nebulizer, ultra-sonic nebulizer, and nebulizer kits. Among these, pneumatic nebulizers are the most demanded product, owing to their aptness for almost all types of medications. In 2014, the pneumatic nebulizers segment held a share of more than 68% in the overall market, reaching to an opportunity worth INR393.53 mn. Expanding at a CAGR of 25.40% between 2015 and 2023, this opportunity is likely to increase to INR3,118.3 mn by 2023.
Mesh nebulizers emerged second in 2014 with a share of nearly 17% in the overall market. Equipped with latest technologies, these nebulizers are highly efficient and perform fast drug delivery, which is why their demand is reported to be increasing significantly. The segment is projected to register a CAGR of 27.1% between 2015 and 2023.
North Zone to Remain Dominant Regional Market for Nebulizers
The India nebulizers market is studied on the basis of its performance in the north zone, east zone, central zone, south zone, and the west zone. In 2014, north zone emerged as the market leader with a share of 35.10%. The increasing prevalence of acute respiratory diseases and chronic obstructive pulmonary disorders, triggered by the escalating level of pollution, has fueled the demand for nebulizers significantly in this zone. Analysts expect a gradual increase in this demand at a CAGR of 27.50% over the period from 2014 to 2023, ensuring the dominance of the north zone during this period.
Nebulizers are also witnessing a high demand in the east zone. According to the department of environment in West Bengal, 70% of people in Kolkata suffer from one or the other form of respiratory conditions, owing the immense environmental pollution. As the pollution continues to rise, the prevalence of respiratory diseases in this zone is projected to witness a considerable increase in the near future, boosting the demand for nebulizers.
Large Participant Pool Makes for Fragmented Competitive Landscape
The nebulizers market in India demonstrates a highly fragmented structure, thanks to the presence of a large pool of participants. Omron Healthcare, Nulife, and Philips Healthcare are at the forefront of this market. Resipirotech Med Solutions Pvt. Ltd., Becton, Dickinson and Co., PARI Respiratory Equipment Inc., Medicare Equipments (India) Pvt. Ltd., Bhasin Sons Private Ltd., Agilent Technologies, Inc., and DeVilbiss Healthcare LLC are some of the other prominent companies operating in this market.

Thursday, 15 December 2016

Cardiac Rehabilitation Market - Latest Trends & Insights 2024

In the highly consolidated global market for cardiac rehabilitation, innovations and product costs will be major determinants of success, marks a recent report by Transparency Market Research. The top two companies in the market, Brunswick Corporation and Technogym, had a clear hold on the market’s overall growth prospects, accounting for a combined share of over 50% in 2015. Other leading vendors such as Brunswick Corporation, Johnson health Tech Co., and Amer Sports, in combination with these two companies, accounted for a share of nearly 70% in the global market in the same year.
Characterized by high competitive rivalry, high rate of introduction of technologically advanced products, and a continuous rise in global demand, the market for cardiac rehabilitation will emerge as a lucrative investment hub for investors in the years to come.
Rising Global Population of Geriatrics to be Major Driver
The world’s population of people aged more than 60 years is rising at a rapid pace, upping the risk of cardiovascular diseases as aging has a major impact on the body’s cardiovascular system. This factor is also the root cause of the increasing rates of morbidity, disability, mortality, and a substantial rise in the world’s healthcare costs. According to the Institute for Health Metrics and Evaluation, the world’s geriatric population suffered a 55% rise in deaths due to cardiovascular diseases between the period of 1990 and 2013.
WHO statistics, on the other hand, highlight another major concern – the high prevalence of cardiovascular diseases and resultant rise in deaths in developing and underdeveloped countries. Low- and middle-income countries in developing and underdeveloped parts of the globe account for a staggering 82% share in the total number of deaths caused due to non-communicable diseases across the world; of these, cardiovascular diseases account for a massive 37% share. Driven with the aim of improving the situation, sustained efforts for preventing and treating cardiovascular diseases undertaken on national and international levels will have a major impact the global cardiac rehabilitation market in the future.
High Product Costs to Constrain Demand for Cardiac Rehabilitation
Being a highly capital- and research-intensive marketplace, cardiac rehabilitation products, quite naturally, carry a high price tag and always carry the risk of being outclassed by newer and most often technologically advanced products in the market. In this highly dynamic market, where the rate of introduction of technologically advanced varieties of product types is immense, the high and rising costs of cardiac rehabilitation products are a major restraints for further expansion. Cost is a major constraint especially for the market’s growth in developing regions such as Asia Pacific and Latin America.
Apart from the factor of cost, low enrolments in cardiac rehabilitation programs and lack of skilled resources providing cardiac rehabilitation services are also major restraints for the global cardiac rehabilitation market. To overcome the challenge of low enrolments, vendors will have to focus more on formulating programs that have flexible schedules and are sensitively priced according to the region of operation. Intervention from government and private educational institutes will be necessary for increasing the number of rehabilitation counsellors on a global front.
The global market for cardiac rehabilitation had a valuation of US$1,010.93 mn in 2015. It will expand at a healthy 5.4% CAGR from 2016 through 2024 and rise to a valuation of US$1,622.9 mn by 2024.
This analysis of the global cardiac rehabilitation market has been based on a recent market research report, titled “Cardiac Rehabilitation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”

Sunday, 9 October 2016

Steam Autoclave Market: Business Challenges, Emerging Technologies & Competitive Landscape

The global steam autoclaves market is marked by intense competitive rivalry and high entry barriers for new vendors, typical of markets featuring high consolidation, reports a recent study by Transparency Market Research (TMR). The oligopolistic market witnesses the dominance of companies such as STERIS, Getinge Group, and Johnson & Johnson, which collectively held close to two-third of the overall market in 2015.
The presence of a very small number of product manufacturers, preference of buyers for long-term contracts with steam autoclave devices manufacturers, and broad product portfolios have further reinforced the standing of leading vendors in the market. Product innovations, production of economic products, and strategies aimed at expansion in emerging regional markets could aid small vendors in the market carve out new growth channels in the near future. Other notable vendors operating amid intense competition in the global steam autoclave market are 3M Health Care, Belimed Group, CISA Group, Matachana Group, CISA Group, and SAKURA SI CO., LTD.
Rising Number of Surgeries and Hospital-acquired Infections Stimulate Adoption of Steam Autoclaves in Healthcare Settings
The vast increase in the number of surgical procedures undertaken across the globe every year has played a major role in the increased consumption of steam autoclaves globally in the past few years. The Centers for Disease Control and Prevention states that in U.S. alone, nearly 46.5 mn surgeries and around 5 mn endoscopies are performed every year. In other regions as well, such as the developing parts of Asia Pacific, which are marked by large population bases and flourishing medical tourism industries, a massive rise in the number of surgical procedures has been seen in the past few years.
Compounding the need for effective sterilization mechanisms in healthcare settings in addition to abovementioned factor is the concern regarding rising prevalence of nosocomial infections across the globe. These factors, in addition to the rising focus on patient safety, will allow the global steam autoclave market gain traction in the next few years.
Technological Advancements to Fuel Market’s Growth
The market has witnessed the introduction of several technologically advanced and increasingly effective products such as E-beam and gamma irradiation, which are further boosting the market’s growth prospects. High product compatibility and low cost of these new products are expected to help the global steam autoclave market gain significant momentum over the forecasting horizon.
However, the increased usage of disposable devices across healthcare settings, which are not meant to be reused and require little or no sanitization over their usable life, could emerge as a major restraint for the overall growth of the market. Moreover, the imposition of excise duty taxes on the manufacturers of medical devices is also expected to hamper the overall profitability of steam autoclaves for vendors, thus resulting in increased product prices. This factor could also have a negative impact on the market’s growth prospects, especially in cost-sensitive developing regions.
In terms of popularity of product varieties available in the market, including traditional steam autoclaves and tabletop steam autoclaves, the market is again highly consolidated. The segment of traditional autoclaves accounted for a share of over 91% in the market in 2015. The segment is also expected to expand at the highest CAGR of 5.8% over the period between 2016 and 2024. North America was the leading regional market in 2015, with nearly 40% share in the market in terms of revenue in 2015.
On a whole, the global autoclave market was worth US$1.57 bn in 2015. Expected to rise at a healthy 5.7% CAGR from 2016 to 2024, the market is projected to touch US$2.57 bn by 2024.
This review is based on a latest market intelligence report published by Transparency Market Research, titled “Steam Autoclave Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Thursday, 6 October 2016

Hearing Aids Market: Preparing for Commercialization – Timing, Challenges and Solutions

Early detection and treatment of hearing loss can mitigate the severity of deafness and could improve the condition of those suffering from the condition. As per World Health Organization, in 2015 the hearing aid production globally, hardly met 10% of the total need and a meager 3% of demand across developing countries. This provides the global hearing aids market with substantial opportunities to gain from in the forthcoming years.
As per Transparency Market Research (TMR), the global hearing aids market is expected to reach US$7.01 bn by 2024, from US$4.7 bn in 2015. Between 2016 and 2024, the global hearing aids market is thus expected to surge at a CAGR of 4.5%.
Increasing Geriatric Population and Awareness to Boost Sales of Hearing Aids
As aged people are more prone to develop hearing impairment, the sales of hearing aids are directly impacted by the current geriatric demographic dynamics in worldwide. In the last of few years, the awareness level among patients and their families regarding hearing impairment has considerably increased. This, combined with the recent advances in the hearing aid technology, is boosting sales of hearing aids worldwide. Furthermore, the advent of rechargeable hearing aids with long lasting and quick charging features will also augment the market’s growth.
Opportunities for the Market in Europe to be Most Lucrative
Regionally, Europe has been exhibiting the most attractive opportunities for companies in the hearing aids market. It emerged dominant with a share of 39% in the global market in 2015. The presence of a large pool of aged people across Western Europe and the increasing willingness among consumers to spend on advanced medical devices have helped Europe attain the lead in the global hearing aids market. The fact that several of the prominent names in the industry are domiciled in the region has also augured well for the market. TMR has pegged the value of the Europe hearing aids market at US$1.8 bn in 2015 and forecasts it to reach US$2.6 bn by the end of 2024, rising at a CAGR 4.1% from 2015 to 2024.
However, the market in Asia Pacific is expected to grow at a fast pace during the forecast period. The prevalence of considerably high unmet medical needs and the rising investment in the health care infrastructure create immense opportunities for sale of hearing aids in Asia Pacific. Besides this, governments across emerging economies are making considerable efforts to educate people about conditions such as health impairments have fuelled demand for hearing aids in the region. As per TMR, the regional market is expected to rise at a CAGR of 5.2% between 2016 and 2024.
Increasing Incidence of Hearing Loss in Children to Necessitate Development of New Products
By end user, the global hearing aids market is bifurcated into adult and pediatric. Of these, the adult segment held approximately 94.83% of the market in 2015.The incidence of hearing impairment is higher in developing and under-developed countries because of the high geriatric population in these countries. However, in the forecast period growth exhibited by the pediatric segment is expected to be faster due to the rising prevalence of hearing loss among children.
Key players in this market are Sonova AG (Switzerland), William Demant Holding (Denmark), Siemens Healthcare (Germany), GN ReSound A/S (Denmark), Starkey (U.S.), and Widex A/S (Denmark), among others.

Wednesday, 5 October 2016

Cardiac Rehabilitation Market will rise to a valuation of US$1,622.9 mn by 2024

That aging has a significant impact on the cardiovascular system of humans is a well-known fact. As the world’s population of people aged more than 60 years rises at an alarming pace, the risk of deaths directly caused by a number of cardiovascular conditions is also rising. The WHO stated that nearly 17.5 mn deaths across the globe occurred due to a cardiovascular disease in 2015, accounting for a massive 31% of total global deaths that year.
Rising geriatric population and heightening concerns regarding the rising burden of cardiovascular diseases on struggling economies are the chief factors driving the increased demand for effective cardiac rehabilitation measures across the globe. Increased awareness regarding the fact that cardiovascular diseases can be prevented by adopting healthy lifestyles are also playing a major role in the rising global consumption of cardiac rehabilitation devices such as stationary bicycle, treadmills, elliptical trainers, heart rate monitors, and rowers. In addition to these factors, the rising intervention of government and private bodies are also playing a major role in raising the awareness regarding preventive measures, cardiac rehabilitation practices, and products.
TMR findings suggest that the global cardiac rehabilitation market expansion at a 5.4% CAGR from 2016 to 2024. The market, which had a valuation of US$1,010.93 mn in 2015, will rise to US$1,622.9 mn by 2024.
Elliptical Trainers to Gain Prominence
Several studies have highlighted the vast and more beneficiary health effects of elliptical trainers, the devices that mimic climbing stairs, in comparison to other devices commonly used for cardio fitness. A study by the National Center for Biotechnology Information (NCBI) states that elliptical trainers have more benefits than exercises such as ground and treadmill walking and cycling. As a result, variety of elliptical trainers, such as seated and upright models, will be the most preferred cardiac rehabilitation products in the years to come.
The segment also dominates presently, accounting for an approximately 27% share of the global market in 2015. The valuation of the elliptical trainers segment is expected to expand at a healthy 6.0% CAGR from 2016 to 2024 in the global cardiac rehabilitation market.
The segment of heart rate monitors is also expected to gain a major push in the global cardiac rehabilitation market in the next few years. Factors that will increase the popularity of heart rate monitors will be the rising technological advancements, increasingly reliable outputs of new-age products, and their portable nature. The segment will expand at an approximately 7% CAGR from 2016 to 2024.
North America to Continue Dominating Global Market but Emerging Economies to Fare Better for Investment Returns
The impact of cardiovascular diseases is especially tasking for developing and underdeveloped economies such as countries in Latin America, Asia Pacific, and Africa. The population in these regions accounts for a huge share of 82% in the overall deaths caused by non-communicable diseases across the world every year. A massive 37% of this is on account of deaths caused due to cardiovascular diseases.
As cardiovascular diseases form a huge burden on the already weak economies of developing and underdeveloped countries, and efforts are being undertaken to raise awareness regarding the need for cardiac rehabilitation for patients with cardiac disorders.
The global cardiac rehabilitation market will gain a sizeable share in the overall revenues from North America, which is presently the dominant regional market, over the period of forecast as well. North America accounted for over 50% share in the global market in 2014. However, developing regions across Asia Pacific and Latin America will lead to the most lucrative returns on investment owing to rising healthcare expenditure and increased awareness among the population. The market in Asia Pacific will expand at the highest CAGR of 6.8% from 2016 to 2024.

Thursday, 19 May 2016

Medical Lifting Slings Market Dynamics and Opportunities Report by Transparency Market Research

According to a new market research report published by Transparency Market Research “Medical Lifting Slings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”, the global medical lifting slings market was valued at US$391.8 mn in 2015 and is estimated to reach US$910.6 mn in 2024, expanding at a CAGR of 9.2% from 2016 to 2024.
Medical lifting slings are devices used in hospitals and nursing homes to transfer patients who have restricted mobility. The medical lifting slings market is driven by factors such as rising geriatric population, favorable government initiatives, and increasing incidence of lifestyle diseases. Moreover, increasing number of accidents and partial immobility incidences have fueled demand and growth of the market in the last decade. However, lack of technical expertise and proper training to handle patients with medical lifting slings in emerging economies coupled with difficulties in handling obese patients with lifting slings hampers market growth. The global medical lifting slings market was valued at US$391.8 mn in 2015 and is projected to reach US$910.6 mn by 2024, expanding at a CAGR of 9.2% from 2016 to 2024.
The universal sling segment dominated the medical lifting slings market in 2015. The dominance of this segment was majorly due to rising demand for universal lifting slings globally and comfortable and secure seating structure. The bariatric sling segment held the smallest share of the market in 2015 due to low average cost compared to other medical lifting sling products.
The universal sling segment is expected to gain market share in 2024 due to comfortable and secure seating structure. The transfer and toileting sling segment is likely to expand at a high CAGR during the forecast period. High growth rate of this segment is attributed to introduction of new supporting applications to provide better quality of life for patients and higher penetration in developing regions.
In terms of sling point, the 4 point sling segment held the largest share of the medical lifting slings market in 2015. The segment is expected to gain market share in 2024, as most products, such as bathing, spa, and hammock slings, fall under this segment. The u-shape sling segment is also estimated to witness strong growth during the forecast period as shorter lifespan results in purchase in large quantity by dealers.
The hospitals end-user segment accounted for the largest share of the market in 2015. The segment is expected to dominate the market during the forecast period. The dominance of the segment is primarily due to high adoption rate and government initiatives to train hospital nurses. Assisted living facilities and home health care have witnessed significant acceptance. Hence, the segment is likely to expand at the highest growth rate in the next few years
The global medical lifting slings market is fragmented, with the presence of many players in the market. Major players operating in the global medical lifting slings market are ArjoHuntleigh, Argo Medical, Inc., Bestcare, LLC, Drive DeVilbiss Healthcare, Etac AB, DJO Global, GF Health Products, Inc., Joerns Healthcare, LLC, Invacare Corporation, and Prism Medical, among others.

Tuesday, 17 May 2016

How to Invest in Medical Billing Outsourcing Market

Transparency Market Research, a leading market intelligence agency, has compiled many reports under the category of healthcare IT, among many others. “Medical Billing Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2023” is a title that falls under this industry category and will provide users with an analysis of the most recent market activity.
Most of the key investments in the global medical billing outsourcing market have always come from government organizations. This is due to the stringent regulatory framework established around this market, which is forcing companies to look for solutions to having an in-house billing team. This rising regulation-based pressure on healthcare organizations is causing key players to rethink their finance allocation structures to make them as cost-effective and functional as possible. The global medical billing outsourcing market thus provides the perfect opportunity for these organizations in reducing their overall expenses.
The rising geriatric population is creating an increased demand for healthcare services around the world. This applies especially to developed nations, where there is a much higher percentage of citizens above 65 years. This, coupled with the surging healthcare expenditure and the complex modern healthcare infrastructure in developed economies, is creating the urgent need for cost-effective solutions for the regions of North America and Europe. As a result, a higher number of organizations are resorting to outsourcing a number of their practices, including billing.
Some of the restraints acting on the global medical billing outsourcing market today are the constantly changing regulatory structure across regions and the steady rate of data migration problems faced by client companies. This makes it complicated to provide standard services for vendors.
From the competitive perspective, the global medical billing outsourcing market is expecting an influx of small and mid-sized healthcare businesses looking to reduce their workload, office space, and overall costs. This is further compounded by the fact that multiple small and mid-sized healthcare organizations do not have the investments or the financial clout to set up their own IT departments. As a result, these organizations find the option of medical billing outsourcing far more feasible and are fast becoming a major driver of this market.
However, the overall pace of the global medical billing outsourcing market’s growth can be hindered by the lack of trust that organizations can place on vendor companies. The amount of trust that each company needs to place on vendors is exceptionally high and therefore any breach of contract can lead to severe consequences for the vendor, while also reduces the trust level that client companies show in the future.
The key players in the global medical billing outsourcing market are Genpact, Accenture, HCL Technologies, and Cognizant Technology Solutions.

Thursday, 12 May 2016

Metabolomics Market: Challenges and Opportunities

MetabolomicsMetabolomics help in the identification and quantification of cellular metabolites by using refined analytical technologies coupled with multi-variant and statistics methods. Metabolomics are used for data mining and for providing functional information of the physiological nature of an organism. Over the past few years, many analytical technologies have been introduced and employed to study metabolites in various organisms, fluids, and tissues. Thanks to the increasing application of metabolomics such as the identification of gene function, monitoring responses to abiotic and biotic stress, and phenotyping of genetically modified plants, the demand for metabolomics is expected to increase in the years to come.
The global metabolomics market is expected to expand at a 17.10% CAGR during the period from 2016 to 2024 to reach US$2.50 bn by 2024. Factors such as the increasing application of metabolomics, the increasing use of metabolomics as a tool in life science, and the increased government spending are expected to propel the global metabolomics market in the near future.
High-performance Liquid Chromatography (HPLC) to Dominate Global Metabolomics Market
The global metabolomics market is segmented on the basis of technique, region, and application. By technique, the global metabolomics market is classified into detection techniques and separation techniques. Gas chromatography, high-performance liquid chromatography (HPLC), and capillary electrophoresis are some of the types of separation techniques. Currently, HPLC dominates the global metabolomics market.
The rapid growth registered by pharmaceutical and biotechnology sectors is expected to propel the global metabolomics market in the next few years. Further, factors such as the rising demand for customized medicines, growing government funding, improved research and development technologies, and the growing need for toxicology testing technologies are expected to benefit the global metabolomics market. However, the lack of skilled professionals in metabolomics science is predicted to restrict the growth of the global metabolomics market in the near future.
By region, the global metabolomics market is divided into North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. Thermo Fisher Scientific, Inc. (U.S.), Biocrates Life Sciences AG (Austria), Waters Corporation (U.S.), LECO Corporation (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Agilent Technologies, Inc.(U.S.), Shimadzu Corporation (Japan), Human Metabolome Technologies, Inc.(Japan), Metabolon, Inc. (U.S.), and Bruker Corporation (U.S.) are some of the key companies operating in the global metabolomics market.
Increasing Use of Metabolomics in Life Sciences Marks Next Major Opportunity
Metabolomics is used to bridge the gap between phenotype and genotype by offering a complete view of functioning of cells. In life science, metabolomics is used as an important tool as it is a relatively precise and faster technique than many others. Metabolomics as a tool in life science can be applied with a particular focus to gain new information about biological systems.
In today’s era of scientific advances, technological developments, and new research methodologies, customized health care provides valuable information to identify and detect the start of various diseases at their early stages. This prevents the development of diseases, thereby increasing the effectiveness of health care systems by enhancing availability, quality, and affordability. The high occurrence of chronic degenerative diseases such as cancer and cardiovascular diseases, especially in developed nations, is expected to propel the global metabolomics market in the near future.

Monday, 1 February 2016

LATAM Adalimumab Market - Industry Analysis, Trends and Forecast 2015 - 2023

According to a new market report published by Transparency Market Research “LATAM Adalimumab Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” the LATAM adalimumab market was valued at US$994.8 mn in 2014 and is expected to reach US$1,186.4 mn by 2023, at a CAGR of 0.4% during the forecast period from 2015 to 2023.
Consistent technological sophistications in development of biosimilar followed by increasing incidence and prevalence of various medical conditions have rendered encouraging growth opportunities for various biological drugs and other innovative biopharmaceuticals. The LATAM adalimumab market by application has been categorized on the basis of the usage of adalimumab for treatment of various medical conditions. Rheumatoid arthritis, psoriasis, Crohn’s disease, and ulcerative colitis constitute the major disorders where adalimumab is prescribed for the treatment. Factors such as improved diagnosis rate followed by the introduction of efficient biologic drugs constitute the significant drivers favoring the market growth.
Adalimumab was first approved in the U.S. for the treatment of aforementioned medical conditions. Currently, this is marketed in more than 60 countries. However, owing to the biologic nature of the drug, it results in high cost and low accessibility in emerging economies such as LATAM and Asia Pacific. On the other hand, with the probable entry of the adalimumab biosimilars post the patent expiry the low costs up to less than 25% to 35% of the originator drugs will boost the uptake and prescription of adalimumab for the treatment of above mentioned medical conditions.
Rheumatoid arthritis application accounted for the largest application segment in LATAM adalimumab market owing to the rigorous research studies and improved lab diagnosis of this condition in Latin America followed by the worldwide acceptance of adalimumab for treatment of rheumatoid arthritis over other drugs. For instance, according to a research paper on ‘Current Therapies in Rheumatoid Arthritis’ published in in Reumatologia Clinica Journal in the year 2013 highlights the current treatment options for rheumatoid arthritis in LATAM. This paper highlights the use of TNF inhibitors of which adalimumab is most commonly used. Furthermore, increased incidence of the disease will favor the uptake of adalimumab to reduce the moderate to severe symptoms of rheumatoid arthritis. However, the risk of infections and other side effects of adalimumab might hamper the market growth
Rheumatoid arthritis and psoriasis application segments are expected to exhibit the highest growth rates during the forecast period from 2015 to 2023 owing to the widespread use and prescription of adalimumab for treatment of these conditions. In addition, increasing healthcare expenditure and preference for biologic drugs will further support the growth of these segments. Currently, majority of the leading market players are focusing on the development of adalimumab biosimilars targeting rheumatoid arthritis and psoriasis. This is evident from the clinical trials conducted to test the safety and efficacy of the adalimumab biosimilars in treating these conditions.
On the other hand, conditions such as Crohn’s disease, ulcerative colitis, and ankylosing spondylitis among others accounted for the smaller market shares as compared to aforementioned segments during the forecast period. This is majorly attributed to the high cost of adalimumab therapy against other alternative therapies which leads to limited accessibility and slow growth. Infliximab accounts for the first drug to be approved for the treatment of Crohn’s disease as compared to adalimumab. However, owing to improving regulatory scenario followed by the probable entry of adalimumab biosimilars with low cost would ensure the slow and steady adoption and acceptance during the forecast period from 2015 to 2023 thereby supporting the market growth. Ulcerative colitis and others segments are anticipated to record lowest growth rate during the forecast period from 2015 to 2023.
Companies such as AbbVie, Inc. Amgen, Inc., Pfizer, Inc., Novartis AG, Mylan N.V. and Boehringer Ingelheim GmbH constitute some of the key market players in adalimumab market. The adalimumab market is influenced by the presence of large regional players and are more frequently used in developed economies as compared to other developing economies.